Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical Research in Cardiology

Open Access 11-12-2023 | Chronic Kidney Disease | Original Paper

Chronic kidney disease is related to impaired left ventricular strain as assessed by cardiac magnetic resonance imaging in patients with ischemic cardiomyopathy

Authors: Rosalia Dettori, Andrea Milzi, Richard Karl Lubberich, Kathrin Burgmaier, Sebastian Reith, Nikolaus Marx, Michael Frick, Mathias Burgmaier

Published in: Clinical Research in Cardiology

Login to get access

Abstract

Introduction

Chronic kidney disease (CKD) is an important cardiovascular risk factor. However, the relationship between CKD and myocardial strain as a parameter of myocardial function is still incompletely understood, particularly in patients with ischemic cardiomyopathy (ICM). Cardiac magnetic resonance imaging (CMR) feature tracking allows to analyze myocardial strain with high reproducibility. Therefore, the aim of the present study was to assess the relationship between CKD and myocardial strain as described by CMR in patients with ICM.

Methods

We retrospectively performed CMR-based myocardial strain analysis in 89 patients with ICM and different stages of CKD, classified according to the KDIGO stages. In all patients, global longitudinal strain (GLS), global circumferential strain (GCS) and global radial strain (GRS) analysis of left ventricular myocardium were performed. Furthermore, segmental longitudinal (SLS), circumferential (SCS) and radial strain (SRS) according to the AHA 16/17-segment model was determined.

Results

Creatinine levels (GLS: r = 0.46, p < 0.001; GCS: r = 0.34, p = 0.001; GRS: r = − 0.4, p < 0.001), urea levels (GLS: r = 0.34, p = 0.001; GCS: r = 0.30, p = 0.005; GRS: r = − 0.31, p = 0.003) as well as estimated glomerular filtration rate (GLS: r = -0.40, p < 0.001; GCS: r = − 0.27, p = 0.012; GRS r = 0.34, p < 0.001) were significantly associated with global strains as determined by CMR. To further investigate the relationship between CKD and myocardial dysfunction, segmental strain analysis was performed: SLS was progressively impaired with increasing severity of CKD (KDIGO-1: − 11.93 ± 0.34; KDIGO-5: − 7.99 ± 0.38; p < 0.001 for KDIGO-5 vs. KDIGO-1; similar data for SCS and SRS). Interestingly, myocardial strain was impaired with CKD in both segments with and without scarring. Furthermore, in a multivariable analysis, eGFR was independently associated with GLS following adjustment for LV-EF, scar burden, diabetes, hypertension, age, gender, LV mass or LV mass index.

Conclusion

CKD is related to impaired LV strain as assessed by CMR in patients with ICM. In our cohort, this relationship is independent of LV-EF, the extent of myocardial scarring, diabetes, hypertension, age, gender, LV mass or LV mass index.
Literature
1.
Ardhanari S, Alpert MA, Aggarwal K (2014) Cardiovascular disease in chronic kidney disease: risk factors, pathogenesis, and prevention. Adv Perit Dial 30:40–53PubMed
2.
Matsushita K, Ballew SH, Coresh J (2015) Influence of chronic kidney disease on cardiac structure and function. Curr Hypertens Rep 17(9):581CrossRefPubMed
3.
4.
Bae EH et al (2012) GFR and cardiovascular outcomes after acute myocardial infarction: results from the Korea Acute Myocardial Infarction Registry. Am J Kidney Dis 59(6):795–802CrossRefPubMed
5.
Nakano T et al (2010) Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study. Am J Kidney Dis 55(1):21–30CrossRefPubMed
6.
7.
Jankowski J et al (2021) Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options. Circulation 143(11):1157–1172CrossRefPubMedPubMedCentral
8.
Wilson PW et al (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97(18):1837–1847CrossRefPubMed
9.
Prevention C.f.D.C.a. (2017) National Chronic Kidney disease Fact Sheet. Department of Health and Human Services, Atlanta, GA
10.
Guerin AP et al (2000) Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15(7):1014–1021CrossRefPubMed
11.
London GM, Guerin AP (1999) Influence of arterial pulse and reflected waves on blood pressure and cardiac function. Am Heart J 138(3 Pt 2):220–224CrossRefPubMed
12.
Gauthier-Bastien A et al (2014) Vascular remodeling and media calcification increases arterial stiffness in chronic kidney disease. Clin Exp Hypertens 36(3):173–180CrossRefPubMed
13.
Salib M et al (2022) Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial. Clin Res Cardiol 111(6):614–626CrossRefPubMed
14.
Alhaj E et al (2013) Uremic cardiomyopathy: an underdiagnosed disease. Congest Heart Fail 19(4):E40–E45CrossRefPubMed
15.
16.
Negishi K et al (2013) Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity. J Am Soc Echocardiogr 26(5):493–498CrossRefPubMed
17.
Negishi K et al (2014) Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection. Eur Heart J Cardiovasc Imaging 15(3):324–331CrossRefPubMed
18.
Polacin M et al (2022) Segmental strain for scar detection in acute myocardial infarcts and in follow-up exams using non-contrast CMR cine sequences. BMC Cardiovasc Disord 22(1):226CrossRefPubMedPubMedCentral
19.
Claus P et al (2015) Tissue tracking technology for assessing cardiac mechanics: principles, normal values, and clinical applications. JACC Cardiovasc Imaging 8(12):1444–1460CrossRefPubMed
20.
Pedrizzetti G et al (2016) Principles of cardiovascular magnetic resonance feature tracking and echocardiographic speckle tracking for informed clinical use. J Cardiovasc Magn Reson 18(1):51CrossRefPubMedPubMedCentral
21.
22.
Stathogiannis K et al (2020) Regional myocardial strain by cardiac magnetic resonance feature tracking for detection of scar in ischemic heart disease. Magn Reson Imaging 68:190–196CrossRefPubMed
23.
Zhang Y et al (2021) The additive effects of kidney dysfunction on left ventricular function and strain in type 2 diabetes mellitus patients verified by cardiac magnetic resonance imaging. Cardiovasc Diabetol 20(1):11CrossRefPubMedPubMedCentral
24.
Terhuerne J et al (2021) Speckle-tracking echocardiography in comparison with ejection fraction for prediction of cardiovascular mortality in patients with end-stage renal disease. Clin Kidney J 14(6):1579–1585CrossRefPubMedPubMedCentral
25.
Jia X et al (2022) Cardiac magnetic resonance imaging parameters show association between myocardial abnormalities and severity of chronic kidney disease. Front Cardiovasc Med 9:1053122CrossRefPubMedPubMedCentral
26.
Weinreb JC et al (2021) Use of intravenous gadolinium-based contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Kidney Med 3(1):142–150CrossRefPubMed
27.
Schulz-Menger J et al (2020) Standardized image interpretation and post-processing in cardiovascular magnetic resonance—2020 update : Society for Cardiovascular Magnetic Resonance (SCMR): Board of Trustees Task Force on Standardized Post-Processing. J Cardiovasc Magn Reson 22(1):19CrossRefPubMedCentral
28.
Cerqueira MD et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Int J Cardiovasc Imaging 18(1):539–542PubMed
29.
Levey AS et al (2020) Nomenclature for kidney function and disease-executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference. Eur Heart J 41(48):4592–4598CrossRefPubMedPubMedCentral
30.
Eckardt KU et al (2013) Evolving importance of kidney disease: from subspecialty to global health burden. Lancet 382(9887):158–169CrossRefPubMed
31.
32.
Tonelli M et al (2006) Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 17(7):2034–2047CrossRefPubMed
33.
Takahashi T et al (2022) Association between cardiovascular risk factors and left ventricular strain distribution in patients without previous cardiovascular disease. J Echocardiogr 20(4):208–215CrossRefPubMedPubMedCentral
34.
Dilsizian V et al (2021) Cardiac imaging for coronary heart disease risk stratification in chronic kidney disease. JACC Cardiovasc Imaging 14(3):669–682CrossRefPubMed
35.
Cimino S et al (2013) Global and regional longitudinal strain assessed by two-dimensional speckle tracking echocardiography identifies early myocardial dysfunction and transmural extent of myocardial scar in patients with acute ST elevation myocardial infarction and relatively preserved LV function. Eur Heart J Cardiovasc Imaging 14(8):805–811CrossRefPubMed
Metadata
Title
Chronic kidney disease is related to impaired left ventricular strain as assessed by cardiac magnetic resonance imaging in patients with ischemic cardiomyopathy
Authors
Rosalia Dettori
Andrea Milzi
Richard Karl Lubberich
Kathrin Burgmaier
Sebastian Reith
Nikolaus Marx
Michael Frick
Mathias Burgmaier
Publication date
11-12-2023
Publisher
Springer Berlin Heidelberg
Published in
Clinical Research in Cardiology
Print ISSN: 1861-0684
Electronic ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-023-02346-6